Literature DB >> 9587562

[Lactic acidosis and hepatic mitochondrial changes during a treatment with zidovudine].

M C Charton-Bain1, M Flamant, J M Aubertin, M F Belair, J Gilquin, M Kazatchkine, P Bruneval.   

Abstract

Adverse effects of zidovudine, which mainly result in myopathies and hematological disorders, could be due to multitissular mitochondrial toxicity of the drug. During zidovudine treatment, most cases of lactic acidosis have been attributed to mitochondrial myopathy. We report a case of hepatocellular failure with lactic acidosis in a 33 year-old patient with the human immunodeficiency virus infection and treated with zidovudine for 8 months. Liver biopsy showed massive macrovacuolar steatosis and ultrastructural mitochondrial abnormalities similar to those previously described in the skeletal muscle. This is the second reported case of lactic acidosis and hepatocellular failure which is probably related to hepatic mitochondrial dysfunction caused by zidovudine.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9587562

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN: 0399-8320


  3 in total

1.  Mitochondrial disruption and apoptosis in lymphocytes of an HIV infected patient affected by lactic acidosis after treatment with highly active antiretroviral therapy.

Authors:  M Tolomeo; S Mancuso; M Todaro; G Stassi; M Catalano; S Arista; G Cannizzo; E Barbusca; V Abbadessa
Journal:  J Clin Pathol       Date:  2003-02       Impact factor: 3.411

Review 2.  Lactic acidosis in HIV infected patients: a systematic review of published cases.

Authors:  A Arenas-Pinto; A D Grant; S Edwards; I V D Weller
Journal:  Sex Transm Infect       Date:  2003-08       Impact factor: 3.519

Review 3.  Bench-to-bedside review: severe lactic acidosis in HIV patients treated with nucleoside analogue reverse transcriptase inhibitors.

Authors:  Yann-Erick Claessens; Jean-Daniel Chiche; Jean-Paul Mira; Alain Cariou
Journal:  Crit Care       Date:  2003-02-28       Impact factor: 9.097

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.